The KEEP SIMPLEST Study: Improving In-House Delays and Periinterventional Management in Stroke Thrombectomy-A Matched Pair Analysis.
Aged
Aged, 80 and over
Clinical Protocols
Conscious Sedation
Endovascular Procedures
Female
Humans
Hypnotics and Sedatives
/ administration & dosage
Intracranial Thrombosis
/ complications
Ketamine
/ administration & dosage
Male
Matched-Pair Analysis
Middle Aged
Propofol
/ administration & dosage
Stroke
/ etiology
Thrombectomy
Time-to-Treatment
Treatment Outcome
Blood pressure
Conscious sedation
Endovascular stroke treatment
General anesthesia
Thrombectomy
Workflow
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
pubmed:
20
1
2019
medline:
16
5
2020
entrez:
20
1
2019
Statut:
ppublish
Résumé
Although the treatment window for mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) has been extended in recent years, it has been proven that recanalizing treatment must be administered as soon as possible. We present a new standard operating procedure (SOP) to reduce in-house delay, standardize periinterventional management and improve patient safety during MT. KEep Evaluating Protocol Simplification In Managing Periinterventional Light Sedation for Endovascular Stroke Treatment (KEEP SIMPLEST) was a prospective, single-center observational study aimed to compare aspects of periinterventional management in AIS patients treated according to our new SOP using a combination of esketamine and propofol with patients having been randomized into conscious sedation (CS) in the Sedation versus Intubation for Endovascular Stroke TreAtment (SIESTA) trial. Primary outcome was early neurological improvement at 24h using the National Institutes of Health Stroke Scale, and secondary outcomes were door-to-recanalization, recanalization grade, conversion rate and modified Rankin Scale (mRS) at 3 months. Door-to-recanalization time (128.6 ± 69.47 min vs. 156.8 ± 75.91 min; p = 0.02), mean duration of MT (92.01 ± 52 min vs. 131.9 ± 64.03 min; p < 0.001), door-to-first angiographic image (51.61 ± 31.7 min vs. 64.23 ± 21.53 min; p = 0.003) and computed tomography-to-first angiographic image time (31.61 ± 20.6 min vs. 44.61 ± 19.3 min; p < 0.001) were significantly shorter in the group treated under the new SOP. There were no differences in early neurological improvement, mRS at 3 months or other secondary outcomes between the groups. Conversion rates of CS to general anesthesia were similar in both groups. An SOP using a novel sedation regimen and optimization of equipment and procedures directed at a leaner, more integrative and compact periinterventional management can reduce in-house treatment delays significantly in stroke patients receiving thrombectomy in light sedation and demonstrated the safety and feasibility of our improved approach.
Sections du résumé
BACKGROUND AND PURPOSE
Although the treatment window for mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) has been extended in recent years, it has been proven that recanalizing treatment must be administered as soon as possible. We present a new standard operating procedure (SOP) to reduce in-house delay, standardize periinterventional management and improve patient safety during MT.
METHODS
KEep Evaluating Protocol Simplification In Managing Periinterventional Light Sedation for Endovascular Stroke Treatment (KEEP SIMPLEST) was a prospective, single-center observational study aimed to compare aspects of periinterventional management in AIS patients treated according to our new SOP using a combination of esketamine and propofol with patients having been randomized into conscious sedation (CS) in the Sedation versus Intubation for Endovascular Stroke TreAtment (SIESTA) trial. Primary outcome was early neurological improvement at 24h using the National Institutes of Health Stroke Scale, and secondary outcomes were door-to-recanalization, recanalization grade, conversion rate and modified Rankin Scale (mRS) at 3 months.
RESULTS
Door-to-recanalization time (128.6 ± 69.47 min vs. 156.8 ± 75.91 min; p = 0.02), mean duration of MT (92.01 ± 52 min vs. 131.9 ± 64.03 min; p < 0.001), door-to-first angiographic image (51.61 ± 31.7 min vs. 64.23 ± 21.53 min; p = 0.003) and computed tomography-to-first angiographic image time (31.61 ± 20.6 min vs. 44.61 ± 19.3 min; p < 0.001) were significantly shorter in the group treated under the new SOP. There were no differences in early neurological improvement, mRS at 3 months or other secondary outcomes between the groups. Conversion rates of CS to general anesthesia were similar in both groups.
CONCLUSION
An SOP using a novel sedation regimen and optimization of equipment and procedures directed at a leaner, more integrative and compact periinterventional management can reduce in-house treatment delays significantly in stroke patients receiving thrombectomy in light sedation and demonstrated the safety and feasibility of our improved approach.
Identifiants
pubmed: 30659468
doi: 10.1007/s12028-018-00667-3
pii: 10.1007/s12028-018-00667-3
doi:
Substances chimiques
Hypnotics and Sedatives
0
Esketamine
50LFG02TXD
Ketamine
690G0D6V8H
Propofol
YI7VU623SF
Types de publication
Journal Article
Observational Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
46-55Références
Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723–31.
doi: 10.1016/S0140-6736(16)00163-X
pubmed: 26898852
Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316:1279–88.
doi: 10.1001/jama.2016.13647
pubmed: 27673305
Jovin TG, Nogueira RG, Investigators D. Thrombectomy 6 to 24 hours after stroke. N Engl J Med. 2018;378:1161–2.
doi: 10.1056/NEJMc1801530
pubmed: 29562149
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18.
doi: 10.1056/NEJMoa1713973
pubmed: 6590673
pmcid: 6590673
Mulder M, Jansen IGH, Goldhoorn RB, et al. Time to endovascular treatment and outcome in acute ischemic stroke: MR CLEAN Registry results. Circulation. 2018;138:232–40.
doi: 10.1161/CIRCULATIONAHA.117.032600
pubmed: 29581124
Mehdiratta M, Woolfenden AR, Chapman KM, et al. Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can J Neurol Sci. 2006;33:214–6.
doi: 10.1017/S031716710000500X
pubmed: 16736733
Ribo M, Boned S, Rubiera M, et al. Direct transfer to angiosuite to reduce door-to-puncture time in thrombectomy for acute stroke. J Neurointerv Surg. 2018;10:221–4.
doi: 10.1136/neurintsurg-2017-013038
pubmed: 28446535
Tan BYQ, Ngiam NJH, Sunny S, et al. Improvement in door-to-needle time in patients with acute ischemic stroke via a simple stroke activation protocol. J Stroke Cerebrovasc Dis. 2018;27:1539–45.
doi: 10.1016/j.jstrokecerebrovasdis.2018.01.005
pubmed: 29422380
Wang H, Thevathasan A, Dowling R, Bush S, Mitchell P, Yan B. Streamlining workflow for endovascular mechanical thrombectomy: lessons learned from a Comprehensive Stroke Center. J Stroke Cerebrovasc Dis. 2017;26:1655–62.
doi: 10.1016/j.jstrokecerebrovasdis.2017.04.021
pubmed: 28579511
Mehta BP, Leslie-Mazwi TM, Chandra RV, et al. Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project. J Am Heart Assoc. 2014;3:e000963.
doi: 10.1161/JAHA.114.000963
pubmed: 25389281
pmcid: 4338685
Rai AT, Smith MS, Boo S, Tarabishy AR, Hobbs GR, Carpenter JS. The ‘pit-crew’ model for improving door-to-needle times in endovascular stroke therapy: a Six-Sigma project. J Neurointerv Surg. 2016;8:447–52.
doi: 10.1136/neurintsurg-2015-012219
pubmed: 26863106
pmcid: 4853568
Schönenberger S, Uhlmann L, Hacke W, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA. 2016;316:1986–96.
doi: 10.1001/jama.2016.16623
pubmed: 27785516
Löwhagen Henden P, Rentzos A, Karlsson JE, et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke Trial (anesthesia during stroke). Stroke. 2017;48:1601–7.
doi: 10.1161/STROKEAHA.117.016554
pubmed: 28522637
Simonsen CZ, Yoo AJ, Sorensen LH, et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2018;75:470–7.
doi: 10.1001/jamaneurol.2017.4474
pubmed: 29340574
pmcid: 5885172
Schönenberger S, Möhlenbruch M, Pfaff J, et al. Sedation vs. Intubation for Endovascular Stroke TreAtment (SIESTA)—a randomized monocentric trial. Int J Stroke. 2015;10:969–78.
doi: 10.1111/ijs.12488
pubmed: 25864723
Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399–424.
doi: 10.1080/00273171.2011.568786
Menon BK, Sajobi TT, Zhang Y, et al. Analysis of workflow and time to treatment on thrombectomy outcome in the Endovascular treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) randomized, controlled trial. Circulation. 2016;133:2279–86.
doi: 10.1161/CIRCULATIONAHA.115.019983
pubmed: 27076599
Menon BK, Almekhlafi MA, Pereira VM, et al. Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR thrombectomy for acute revascularization study. Stroke. 2014;45:2024–9.
doi: 10.1161/STROKEAHA.114.005050
pubmed: 24876244
Nii K, Hanada H, Hiraoka F, Eto A, Mitsutake T, Tsutsumi M. Usefulness of consciousness sedation with dexmedetomidine and pentazocine during endovascular treatment for acute stroke. Neurol Med Chir (Tokyo). 2018;58:79–84.
doi: 10.2176/nmc.oa.2017-0188
Whalin MK, Lopian S, Wyatt K, et al. Dexmedetomidine: a safe alternative to general anesthesia for endovascular stroke treatment. J Neurointerv Surg. 2014;6:270–5.
doi: 10.1136/neurintsurg-2013-010773
pubmed: 23761479
Jalili M, Bahreini M, Doosti-Irani A, Masoomi R, Arbab M, Mirfazaelian H. Ketamine-propofol combination (ketofol) vs propofol for procedural sedation and analgesia: systematic review and meta-analysis. Am J Emerg Med. 2016;34:558–69.
doi: 10.1016/j.ajem.2015.12.074
pubmed: 26809929
Debailleul AM, Fichten A, Krivosic-Horber R. Target-controlled infusion with propofol for neuro-anesthesia. Ann Fr Anesth Reanim. 2004;23:375–82.
doi: 10.1016/j.annfar.2004.02.038
pubmed: 15120784
Devlin JW, Mallow-Corbett S, Riker RR. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med. 2010;38:S231–43.
doi: 10.1097/CCM.0b013e3181de125a
pubmed: 20502176
Yan JW, McLeod SL, Iansavitchene A. Ketamine-propofol versus propofol alone for procedural sedation in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2015;22:1003–13.
doi: 10.1111/acem.12737
pubmed: 26292077
Bell JD. In vogue: ketamine for neuroprotection in acute neurologic injury. Anesth Analg. 2017;124:1237–43.
doi: 10.1213/ANE.0000000000001856
pubmed: 28079589
Green SM, Roback MG, Kennedy RM, Krauss B. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57:449–61.
doi: 10.1016/j.annemergmed.2010.11.030
pubmed: 21256625